News - Bavarian Nordic
WEBSep 12, 2024 · Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox Vaccine. July 18, 2024 | Company Announcements. Bavarian Nordic Receives EMA Filing Acceptance and Validation of the MAA for its Chikungunya Vaccine.
News - Bavarian Nordic
WEBInvestors. We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner. Read more. Annual Report 2023. News.
News | Bavarian Nordic
WEBJun 10, 2022 · Bavarian Nordic Receives an Additional Order for JYNNEOS Smallpox and Monkeypox Vaccine from the U.S. Government . BARDA has ordered 500,000 doses of liquid-frozen JYNNEOS ® to be manufactured from existing bulk vaccine for delivery in 2022; Order brings the total U.S. inventory of liquid-frozen JYNNEOS to nearly 2 …
News - Bavarian Nordic
WEBU.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic. Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS ® vaccine, bringing deliveries in 2022 and 2023 to a total of nearly 7 million doses.
News | Bavarian Nordic
WEBNov 9, 2022 · Bavarian Nordic Announces Interim Results for the First Nine Months of 2022. COPENHAGEN, Denmark, November 9, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2022 and business progress for the third quarter of 2022.
News - Bavarian Nordic
WEBDec 6, 2021 · Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 Variants
News | Bavarian Nordic
WEBSep 5, 2024 · Vaccine donations from the European Commission, the U.S. government and Bavarian Nordic are now entering the DRC, the epicenter of the mpox outbreak. More than 250,000 doses to arrive over the next week, marking a crucial turning point in the combat against mpox in Africa.
News | Bavarian Nordic
WEBAug 22, 2024 · Bavarian Nordic confirms its new guidance for the full year at the upper end of the range, with aggregated revenue of approximately DKK 5,300 million and EBITDA of approximately DKK 1,350 million. The public preparedness revenue included in the new guidance is now largely all secured by contracts.
News | Bavarian Nordic
WEBMay 8, 2024 · Bavarian Nordic remains on track for submission of the MAA in the first half of 2024. Bavarian Nordic hosted a capital markets day in February, providing an update on the Company’s business and strategy, including the discontinuation of its …
News | Bavarian Nordic
WEBAug 17, 2024 · Since 2022, Bavarian Nordic has created a vaccine inventory to provide a surge capacity for potential outbreaks. In response to recent events, the company also plans to ramp-up vaccine manufacturing to ensure the continued equitable access to …